tradingkey.logo

Jade Biosciences Inc <JBIO.OQ> expected to post a loss of 43 cents a share - Earnings Preview

ReutersAug 8, 2025 12:46 PM
  • Jade Biosciences Inc JBIO.OQ JBIO.O is expected to show no change in quarterly revenue when it reports results on August 11 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Jade Biosciences Inc is for a loss of 43 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Jade Biosciences Inc is $16.50, about 55.6% above its last closing price of $7.32

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-4.55

-8.40

-3.15

Beat

62.5

Dec. 31 2025

-6.65

-8.75

-6.65

Beat

24

Sep. 30 2024

-21.70

-20.39

-19.60

Beat

3.9​

Jun. 30 2024

-28.65

-28.77

-30.10

Missed

-4.6

​​Mar. 31 2024

-26.83

-26.77

-29.05

Missed

-8.5

Dec. 31 2023

-24.80

-24.77

-25.90

Missed

-4.6​

Sep. 30 2023

-24.42

-24.21

-24.85

Missed

-2.7

Jun. 30 2023

-24.63

-24.36

-26.60

Missed

-9.2

This summary was machine generated August 8 at 12:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI